News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>M Stanley Raises JD HEALTH (06618.HK) Rev./ Profit Forecasts, Adds TP to $46
Morgan Stanley adjusted its results forecasts for JD HEALTH (06618.HK), projecting a 19.7% YoY increase in 2Q25 revenue. Of which, drug sales are expected to grow at low 20-30%, wh...
Reset
Send
The window will close in 5 seconds
<Research>M Stanley Raises JD HEALTH (06618.HK) Rev./ Profit Forecasts, Adds TP to $46
Close
Recommend
8
Positive
9
Negative
5
 
SHORT SELL
 
STOCK INFO

Morgan Stanley adjusted its results forecasts for JD HEALTH (06618.HK)  +1.600 (+3.505%)    Short selling $42.09M; Ratio 20.827%   , projecting a 19.7% YoY increase in 2Q25 revenue. Of which, drug sales are expected to grow at low 20-30%, while sales of nutritional products and medical equipment will achieve double-digit YoY growth.

Morgan Stanley raised its 2025-2027 revenue forecasts for the Company by 2.4%, predicting YoY growth rates of 18%/ 14%/ 12% each, and adjusted net profit forecasts by 1-3%. The broker also added its target price from $45 to $46, with rating kept at Equalweight.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-07-17 12:25.)

Related NewsNomura Lifts JD HEALTH's TP to HKD52, Expecting 1H Rev. & Earnings to Beat

AASTOCKS Financial News
Website: www.aastocks.com
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.